It has been about a month since the last earnings report for Intuitive Surgical, Inc. (ISRG) . Shares have added about 7.1% in that time frame, outperforming the S&P 500.But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Intuitive Surgical due for a pullback? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for Intuitive Surgical, Inc. before we dive into how ...

Core Insights - Universal Health Services, Inc. (UHS) reported third-quarter 2025 adjusted earnings per share (EPS) of $5.69, exceeding the Zacks Consensus Estimate by 22.1% and reflecting a year-over-year increase of 53.4% [1][8] - Net revenues reached $4.5 billion, marking a 13.4% year-over-year improvement and surpassing the consensus mark by 4.2% [1][8] Financial Performance - Adjusted EBITDA, net of non-controlling interests (NCI), increased by 27.4% year over year to $670.6 million, exceeding the estimate of $577.4 million [3][8] - Total operating costs were $4 billion, rising 11% year over year due to higher salaries, wages, benefits, and supplies, which was above the estimated $3.9 billion [3] Segment Performance - **Acute Care Hospital Services**: Adjusted admissions grew 2% on a same-facility basis, with adjusted patient days up 0.4% year over year and net revenue per adjusted admission increasing by 9.8%. Net revenues from acute care services improved by 12.8% on a same-facility basis [4] - **Behavioral Health Care Services**: Adjusted admissions rose 0.5% on a same-facility basis, with adjusted patient days increasing by 1.3% and net revenue per adjusted patient day advancing by 7.9%. Net revenues from behavioral healthcare services improved by 9.3% on a same-facility basis [5] Cash and Debt Position - As of September 30, 2025, UHS had cash and cash equivalents of $112.9 million, a decrease of 10.4% from the end of 2024. The company has an available borrowing capacity of $965 million under its $1.3 billion revolving credit facility [6] - Long-term debt stood at $4 billion, down 11.5% year over year, with current maturities totaling $740.2 million. Total equity increased by 7.1% to $7.2 billion [7] Share Repurchase and Guidance - UHS repurchased shares worth approximately $234.3 million in the third quarter and approved a $1.5 billion increase to its stock repurchase program, bringing the total remaining authorization to $1.8 billion [9] - The company revised its 2025 guidance, forecasting net revenues between $17.306 billion and $17.445 billion, indicating a 9.8% growth from 2024. Adjusted EBITDA is now expected to be in the range of $2.569 billion to $2.619 billion [10][11]

Core Insights - Intuitive Surgical (ISRG) reported strong second-quarter 2025 results, with adjusted earnings per share (EPS) of $2.19, exceeding estimates by 14.1% and showing a 23% year-over-year improvement [1][11] - Revenue reached $2.44 billion, reflecting a 21% increase year over year, driven by higher installed systems and increased da Vinci procedure volume [2][9] Revenue Details - Total revenues of $2.44 billion surpassed the Zacks Consensus Estimate by 3.9% [2] - Revenue growth was consistent at constant currency, indicating strong operational performance [2] Segmental Performance - **Instruments & Accessories**: Revenue of $1.47 billion, up 18.5% year over year, driven by a 17% increase in da Vinci procedure volume and significant growth in Ion and SP platform procedures [3] - **Systems**: Revenue of $574.7 million, up 28.2% year over year, supported by increased system placements and higher average selling prices, with 395 da Vinci systems shipped [4] - **Services**: Revenue of $391.2 million, reflecting a 23.3% increase from the previous year [5] Margins and Expenses - Adjusted gross profit was $1.66 billion, a 17.8% year-over-year increase, with a gross margin of 67.9%, down 200 basis points from the prior year [6] - Selling, general and administrative expenses rose to $561.2 million, up 6.8% year over year, while research and development expenses increased to $313.3 million, up 11.9% [6] Operating Performance - Adjusted operating income totaled $946.6 million, a 25.5% year-over-year increase, with an operating margin of 38.8%, up 130 basis points from the previous year [7] Financial Position - The company ended the quarter with cash, cash equivalents, and investments totaling $9.53 billion, an increase from $9.1 billion in the previous quarter [8] - Total assets increased to $20.16 billion from $19.22 billion a year ago [10] Market Outlook - ISRG raised its 2025 procedure growth guidance to 15.5-17% and updated gross margin guidance to 66-67% [15] - The da Vinci 5 system saw broad launch with 180 placements, contributing to a total installed base of 689 [12] - Global da Vinci procedures increased by 17% year over year, with notable growth in both domestic and international markets [13]

Company Overview - Intuitive Surgical (ISRG) received FDA clearance for its Vessel Sealer Curved, a multifunctional instrument for da Vinci surgical systems, enhancing procedural efficiency in minimally invasive surgeries [2][5] - The Vessel Sealer Curved integrates advanced bipolar energy technology with refined mechanical design, improving performance and precision in robotic-assisted surgeries [3][9] - The new instrument can grasp, dissect, coagulate, and transect tissue, increasing procedural efficiency and broadening the appeal of robotic-assisted surgery across specialties [5][10] Financial Performance - ISRG has a market capitalization of $183.59 billion and an earnings yield of 1.45%, which is higher than the industry's negative 2.88% [6] - In the last reported quarter, ISRG delivered an earnings surprise of 5.85% [6] Stock Performance - Following the FDA clearance announcement, ISRG shares traded flat, with a year-to-date loss of 1.8%, compared to the industry's 11.5% decline and the S&P 500's gain of 5.6% [4] Industry Prospects - The global surgical robots market is projected to grow from $4.31 billion in 2024 to $7.42 billion by 2030, with a CAGR of 9.42% from 2025 to 2030, driven by technological innovation and increasing investments [13]